recMAGE-A3+AS15 ASCI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recMAGE-A3+AS15 ASCI, covering 2019-12-20 to 2019-12-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC [Phase 2]